Success Story: NIW Approved Without RFE! We Helped a Biotechnology Expert Secure Success
Client’s Testimonial:
"Chen was great and answered my questions carefully during my I-140 NIW application. I have recommended their services to my peers. I truly appreciate their work and highly recommend them to other colleagues.”
On April 29th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Post-Doctoral Fellow in the Field of Biotechnology (Approval Notice).
General Field: Biotechnology
Position at the Time of Case Filing: Post-Doctoral Fellow
Approval Notice Date: April 29th, 2026
Processing Time: 18 months, 1 day
Case Summary:
Our firm is pleased to share that an I-140 NIW petition has been approved for an expert in biotechnology, specializing in disease mechanisms, therapeutic approaches, pharmacology, and biomedicine. Our expert team carefully prepared the petition to demonstrate the national importance of the client’s research and the client’s strong positioning to continue advancing treatments for incurable and impactful human diseases.
Client Background and Proposed Endeavor
Holding a Ph.D. in experimental medicine, the client has developed a robust research background in biotechnology and disease-focused therapeutic development. The proposed endeavor is to continue investigating disease mechanisms and therapeutic approaches for novel applications in pharmacology and biomedicine. This work aims to enhance the treatment of uncured and impactful human diseases, bridging the gap between laboratory research and clinical application.
National Significance of the Research
We emphasized that the client’s research carries clear national importance because it contributes to the development of therapeutic approaches for chronic diseases. In the petition, we demonstrated the client’s significance by connecting this research to biotechnology as a critical and emerging technology area, the national need to reduce the burden of chronic disease, and the client’s documented ability to generate findings that other researchers have used in related investigations.
Impressive Credentials and Achievements
To further strengthen the case, we highlighted the client’s objective record of research achievement:
- Publications: 5 peer-reviewed journal articles and 6 abstracts.
- Citations: The published body of work has been cited 127 times at the time.
- Peer Review Service: 1 peer review completed for a recognized journal in the field.
- Funding: Research supported by the Research Association and the Government Research Foundation.
Case Outcome
The client’s contributions to biotechnology, pharmacology, and biomedicine position them to continue advancing research with meaningful potential for improving treatment strategies for serious human diseases. We are honored to have supported this I-140 NIW approval and extend our sincere best wishes for continued success in their research and career pursuits.